ServiceNow: The Post-Earnings Dip Is A Major Opportunity

ServiceNow's AI net new ACV grew 65% year over year, and the company raised its 2026 AI ACV target to $1.7B; Control Tower bookings increased 6x year over year. Q4 cRPO guidance decelerated to 18.5%, though the article argues underlying factors indicate a more modest slowdown than the market reaction suggested. The author retains a Strong Buy rating despite recent share-price volatility.

Analysis

The key debate is whether AI demand is becoming durable, monetizable platform spend—or remains a bookings narrative ahead of revenue. ACV is a leading indicator, not recognized revenue; the raised target matters only if it converts into renewals, expansion, and sustained cRPO without materially higher delivery costs. Control Tower’s growth may be strategically meaningful, but a multiple-of-growth figure can be amplified by a small starting base, so absolute bookings and customer adoption are more informative.

Near term, cRPO deceleration remains a legitimate valuation risk for a premium-growth software name; investors should not assume the market misread it without seeing the reconciliation behind management’s adjustments. Over the next 1–3 months, watch cRPO, subscription revenue, and evidence that AI contracts are incremental rather than bundled into existing commitments. Over 6–18 months, successful workflow automation could strengthen ServiceNow’s platform position and raise switching costs, while also intensifying competition for enterprise software budgets from Salesforce and Microsoft. Implementation capacity and customer returns could constrain adoption even if demand signals remain strong.

The contrarian opportunity is that bookings conversion may lag the AI narrative, leaving room for further multiple compression despite strong ACV indicators. Conversely, a stabilization in cRPO alongside continued AI expansion would challenge that caution. No valuation, price, or detailed cRPO bridge is supplied, so conviction should remain conditional.

Key Decisions for Investors

• Maintain a measured long bias in NOW rather than chase the AI metrics; consider adding in stages only if cRPO stabilizes and subscription growth confirms bookings conversion.
• For the next earnings update, verify the absolute scale and mix of AI and Control Tower bookings, renewal/expansion contribution, and whether AI commitments are incremental. Treat growth multiples without that base information as weak evidence.
• Trim or hedge the long thesis if cRPO continues to decelerate alongside weaker subscription guidance, or if management cannot substantiate conversion of AI ACV into recurring revenue. A sustained cRPO recovery with stable execution would falsify the downside case.